EverHint Signal — EMA10 × EMA30 Crossover — December 22, 2025

What This Signal Is (Quick)

The EMA10 × EMA30 crossover strategy tracks momentum shifts between two exponential moving averages. When the 10-day EMA crosses above the 30-day EMA, it signals accelerating upward momentum—a potential entry point for swing trades. When it crosses below, it suggests weakening momentum and possible exit opportunities.

This is an experimental scanner designed for educational purposes and back-testing. Unlike slower crossover strategies (like EMA10 × SMA50), this pairing uses two exponential averages, making it more responsive to price changes. That means more frequent signals, but also higher sensitivity to market noise in choppy conditions.

Today's scan captured 37 buy signals and 11 sell signals across multiple sectors, with notable concentration in Healthcare, Energy, and Technology.

How We Ranked Today (Reader Version)

Stocks are ranked by RSI(14), with lower RSI values ranked higher for buy signals (indicating more oversold conditions with potential upside) and higher RSI for sell signals. This creates a natural framework for identifying momentum shifts with favorable risk/reward profiles.

We overlay three critical data points:

• Insider Net Flows (last 90 days): Net insider purchases minus sales. Positive = bullish insider sentiment.
• Days → Earnings: Proximity to next earnings report. <7 days = high event risk.
• Analyst Coverage: Number of analysts providing estimates (more coverage = more institutional attention).

These signals are for educational use and back-testing only—not financial advice.

📈 Buy-Side Signals

37 stocks triggered EMA10 crossing above EMA30 on December 22, 2025. Here are the top opportunities ranked by RSI:

Recent Headlines

• QBTS - D-Wave Quantum: D-Wave announces participation in CES 2026, showcasing commercial quantum computing applications. Stock continues to attract attention from Wall Street analysts with coverage initiations. Multiple reports highlight the company's quantum annealing technology and growing customer base.

• BLK - BlackRock: Eni and BlackRock's GIP finalized CCS deal, taking joint control of carbon capture unit. BlackRock Canada announced changes to certain ETF management fees. Multiple institutional holdings updates reflect ongoing portfolio adjustments.

• PCOR - Procore Technologies: Founder and Chairman Tooey Courtemanche to deliver keynote at Building for Tomorrow Summit. Institutional investors adjusting positions with notable insider selling activity in recent months.

• CCJ - Cameco: Uranium stocks gaining attention as nuclear comeback narrative strengthens for 2026. Analysts highlighting uranium mining growth and evolution into one-stop nuclear energy solutions.

• AAOI - Applied Optoelectronics: Introduced new ultra high-power 400-milliwatt narrow-linewidth pump laser for silicon photonics and co-packaged optics in AI data centers.

• ARMK - Aramark: Strengthened community partnerships across national parks through volunteerism, food donations, and community engagement programs.

• PCVX - Vaxcyte: Granted FDA Fast Track designation for QTORIN rapamycin gel. Mizuho Securities maintains top pick status with bullish 250% upside target despite rough 2025.

• RPRX - Royalty Pharma: Acquired royalty interest in Nuvalent's neladalkib and zidesamtinib for up to $315 million. Significant insider selling activity with -$4.2M net insider flow.

• NFG - National Fuel Gas: Highlighted as strong value stock with high-growth dividend profile. Natural gas stocks well-positioned as LNG exports and price forecasts strengthen.

• News Corp (NWS/NWSA): U.S. luxury home market shows mixed pricing with national luxury prices softening to $1.20M (-2.3% YoY). Flipped homes losing pricing power as mortgage rates impact buyer demand.

📉 Sell-Side Signals

11 stocks triggered EMA10 crossing below EMA30, suggesting weakening momentum:

Recent Headlines

• IRON - Disc Medicine: Significant insider selling with -$60M net insider flow over 90 days. Multiple insider transactions by executives and directors.

• AR - Antero Resources: Natural gas stocks positioned to gain as LNG exports rise. Infinity Natural Resources published updated hedge positions following acquisition of Ohio Utica Shale assets from Antero.

• PHM - PulteGroup: Del Webb Explore breaks ground on model homes at North River Ranch, marking first Del Webb Explore community in Florida. Housing affordability becoming policy emergency as shortage pressures Washington.

• DHI - D.R. Horton: Housing stocks under pressure as affordability crisis deepens. Earnings approaching in 29 days with $1.98 EPS estimate.

• HCA - HCA Healthcare: Insider selling activity with -$1.8M net insider flow. Earnings in 32 days with $7.39 EPS estimate.

• CAG - Conagra Brands: Announced quarterly dividend payment of $0.35/share. Analyst views broken narrative creating rare yield opportunity at 7.9% yield, though volume declines and consumer trading down to private labels persist.

Field Notes

RSI(14) Interpretation:

• < 30: Deeply oversold (potential bounce candidates)
• 30-50: Oversold to neutral (value territory)
• 50-70: Bullish momentum building
• > 70: Overbought (strong momentum but potential pullback risk)

Insider Net Flows:
This represents net insider buying minus selling over the last 90 days. Negative values = net selling, which can signal insiders taking profits or reducing exposure. Positive values = net buying, often viewed as bullish. However, many stocks show $0 net flow, indicating either no recent insider activity or offsetting transactions.

Notable insider activity:

• IRON (sell signal): -$60M net selling (large insider exit)
• PCOR (buy signal): -$23.7M net selling (ongoing insider exits)
• QBTS (buy signal): -$5.3M net selling despite strong price momentum
• RPRX (buy signal): -$4.2M net selling
• ADPT (buy signal): -$8.9M net selling
• SEZL (buy signal): +$70K net buying (small but positive)

Sector Rotation Observations:

• Healthcare dominates buy signals (12 stocks), with most showing low RSI (oversold territory)
• Energy appears on both sides: 5 buy signals (uranium/gas plays) vs. 3 sell signals (traditional oil/gas)
• Technology shows 7 buy signals, including quantum computing (QBTS) and enterprise software (DOCU, PCOR, NCNO)
• Consumer Cyclical sell signals (PHM, DHI) reflect housing market headwinds

Earnings Proximity:

• BLK (30 days) and DHI (29 days) are closest to earnings on buy/sell lists respectively
• Most signals have 40-70 days until next earnings, providing runway for swing trades without immediate event risk

Vlad's Take (EverHint)

Market Backdrop: December 22 closed with mixed sentiment. The S&P 500 gained +0.19% to 6,878, Nasdaq slipped -0.09% to 23,429, and the Dow advanced +0.31% to 48,363. Tech showed relative weakness despite the broader advance. The VIX closed at 14.12 (-6.86% on the day), indicating low volatility—a complacent market environment with room for swing trades. Small-caps (Russell 2000) gained +0.64%, outpacing large-caps and suggesting broadening market participation. Crypto showed weakness with Bitcoin -0.14% at $88,512 and Ethereum -0.23% at $2,994. Overall: Cautiously bullish with low-vol conditions favoring active strategies.

Strategy Context: The EMA10×EMA30 crossover is giving us 37 fresh buy signals in this low-volatility environment—good timing. When the VIX is under 15, there's typically less whipsaw risk, and momentum signals have room to develop. But pay attention to sector divergence: Healthcare is flashing the most oversold buy signals (IFF, RPRX, ADPT all under RSI 45), while homebuilders (DHI, PHM) and healthcare services (HCA) are triggering sell signals. That's classic sector rotation.

What I'm Watching:

1. Healthcare oversold bounce: IFF (RSI 38), RPRX (RSI 37), and ADPT (RSI 41) are statistically oversold on this EMA cross. If market breadth holds, these could offer tiered entry opportunities.
2. Quantum computing hype cycle: QBTS has RSI 70 (overbought) but strong momentum. CES 2026 announcement is catalyzing interest. This is a "trade the momentum, not the fundamentals" setup—tighten stops.
3. Insider selling as contra-indicator: Massive insider selling in IRON (-$60M), PCOR (-$24M), and QBTS (-$5M) doesn't mean the signals are broken—it often means executives are taking profits after strong runs. Watch for stabilization.
4. Energy split personality: Uranium names (CCJ, NXE, DNN) are buy signals; traditional oil/gas (AR, SU, VIST) are sell signals. The nuclear revival narrative is gaining traction while fossil fuels consolidate.

Trading Approach:

• For buy signals: Consider tiered entries on the low-RSI names (IFF, RPRX, ADPT) with 20-30% initial positions. Let the crossover confirm with volume. Use the 30-day EMA as your risk management line.
• For sell signals: If you're holding DHI, PHM, or HCA from prior entries, this crossover is your technical exit signal. Don't fight momentum shifts—housing and healthcare service stocks are telegraphing weakness.
• Risk management: With VIX at 14, the market isn't pricing much fear. That's good for breakouts, but also means gaps can happen fast. Keep position sizes reasonable and don't chase the high-RSI names (>70) without a clear catalyst.

The low-VIX, sector-rotation environment is ideal for this crossover strategy. Focus on the oversold Healthcare names and the uranium narrative on the buy side. Respect the sell signals in homebuilders—that sector's been telegraphing trouble for weeks.

💡 If this breakdown was useful, feel free to like, share, or subscribe. Every bit of support matters.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/